Skin healing promoted by acute psychological stress in mice
Brief, acute psychological stress promoted healing in mouse models of three different types of skin irritations, in a study led by UC San Francisco researchers.
Author Archives: Dermatology News From Medical News Today
FDA approves Orbactiv to treat skin infections
The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Climate change could drive rise in debilitating disease
A disease prevalent in developing countries could be spread by the changes in rainfall patterns according to a new study.
Study identifies genetic variants associated with severe skin reactions to commonly used antiepileptic drug
Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin, according to a study in the August 6 issue of JAMA.
Wound closure involves cooperative compression
The process by which wounds are repaired is more complex than was previously thought, reports a paper published online this week in Nature Physics.
Eight steps to avoid insect stings
Stinging insects are as much a part of summer as pool parties and picnics. But don't let these uninvited guests spoil your family's fun.
Pathogen behavior influenced by communication between nostril/skin microbiome bacteria
A team of scientists has made an important discovery about the molecular interactions that occur between generally benign species of Propionibacterium bacteria and the pathogenic bacterium...
New ways science reaches the public: study of dermatology on YouTube
YouTube is for more than watching World Cup highlights, Brian Williams refreshing old school rap classics, and videos of skateboarders landing in unfortunate positions on railings.
Two-gene test differentiates psoriasis from eczema
After analyzing the molecular processes involved, researchers in Germany have developed a test that can differentiate psoriasis from eczema on the basis of only two genes.
Positive results from Phase 2b study of dupilumab in patients with moderate-to-severe atopic dermatitis announced
Sanofi and Regeneron Pharmaceuticals, Inc. have announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe...